<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/7449" />
  <subtitle />
  <id>http://localhost:8080/xmlui/handle/123456789/7449</id>
  <updated>2026-04-13T13:12:33Z</updated>
  <dc:date>2026-04-13T13:12:33Z</dc:date>
  <entry>
    <title>Direct Medical Cost Analysis of Dengue Patients: A Retrospective Study</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/7486" />
    <author>
      <name>Noor Faridah, Imaniar</name>
    </author>
    <author>
      <name>Lia Syahfitr, Tuty</name>
    </author>
    <author>
      <name>Aditya Nugroho, Reza</name>
    </author>
    <author>
      <name>Supadmi, Woro</name>
    </author>
    <author>
      <name>Dania, Haafizah</name>
    </author>
    <author>
      <name>Aryani Perwitasari, Dyah</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/7486</id>
    <updated>2024-11-07T04:37:56Z</updated>
    <published>2022-08-31T00:00:00Z</published>
    <summary type="text">Title: Direct Medical Cost Analysis of Dengue Patients: A Retrospective Study
Authors: Noor Faridah, Imaniar; Lia Syahfitr, Tuty; Aditya Nugroho, Reza; Supadmi, Woro; Dania, Haafizah; Aryani Perwitasari, Dyah
Abstract: Abstract&#xD;
Background: Dengue infection is an arboviral disease that could lead to severe illness. The incidence of severe&#xD;
dengue will impact patients' financial aspects. As an important clinical feature, platelet level on admission day&#xD;
might contribute to the direct medical cost. Objective: This study aimed to examine the direct medical cost among&#xD;
patients with dengue fever (DF) or dengue hemorrhagic fever (DHF) in Yogyakarta, Indonesia. Methods: This&#xD;
study was a retrospective study conducted in two private hospitals in Yogyakarta, Indonesia. Participants included&#xD;
in this study were hospitalized patients diagnosed with DF or DHF. Data were extracted from medical records&#xD;
and finance departments in each hospital. Results: Among 174 dengue patients included in this study, the mean&#xD;
age of DHF patients (18.44 + 14.87) was lower than in DF patients (23.47 + 18.99). Patients with DHF (4.88&#xD;
days) also showed prolonged hospitalization compared with DF (4.18 days) patients. In terms of medical cost,&#xD;
DHF patients need a higher dengue treatment cost, which is about 329.74 USD compared to 220.68 USD for DF&#xD;
patients in hospital 2. Mainly related to room charges, which increased by 9.48% in hospital 1 and 66.28% in&#xD;
hospital 2 compared with DF patients. Furthermore, DHF patients with thrombocytopenia on the first day of&#xD;
admission present higher medical costs in terms of laboratory fees (36.08%), medicine (18.17%), and total medical&#xD;
costs (9.84%). Conclusion: Severe form of dengue will contribute to economic burden. Therefore, prevention and&#xD;
adequate treatment are essential to reduce the prognosis of severe dengue and higher medical cost.&#xD;
Keywords: dengue, infection, medical cost</summary>
    <dc:date>2022-08-31T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Acute and Subchronic Toxicity of Indonesian House Dust Mites (IHDM) Allergenic Extract for Asthma Allergy Immunotherapy</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/7485" />
    <author>
      <name>Setiya Budiatin, Aniek</name>
    </author>
    <author>
      <name>Alif Pratama, Yusuf</name>
    </author>
    <author>
      <name>Fatma Sari, Winda</name>
    </author>
    <author>
      <name>Rahmadi, Mahardian</name>
    </author>
    <author>
      <name>Taher, Muhammad</name>
    </author>
    <author>
      <name>Amiruddin Zakaria5, Zainul</name>
    </author>
    <author>
      <name>Khotib, Junaidi</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/7485</id>
    <updated>2024-11-07T04:39:47Z</updated>
    <published>2022-08-31T00:00:00Z</published>
    <summary type="text">Title: Acute and Subchronic Toxicity of Indonesian House Dust Mites (IHDM) Allergenic Extract for Asthma Allergy Immunotherapy
Authors: Setiya Budiatin, Aniek; Alif Pratama, Yusuf; Fatma Sari, Winda; Rahmadi, Mahardian; Taher, Muhammad; Amiruddin Zakaria5, Zainul; Khotib, Junaidi
Abstract: Abstract&#xD;
Background: In developing a pharmaceutical product, it is necessary to conduct pre-clinical and clinical trials to&#xD;
ensure its safety and effectiveness. The toxicity test is conducted to assess the safety of a substance to determine&#xD;
its toxic effect of the substance. Objective: This study aims to determine the acute and subchronic toxicity of&#xD;
administering IHDM allergenic extract using experimental animal models. Methods: Female BALB/c mice and&#xD;
female and male Wistar rats were used as experimental animal models. While the IHDM allergenic extract was&#xD;
used with the level of Der p1 is 11.3-26.6 ng/mL and was administered by intravenous route. The acute toxicity&#xD;
test was carried out for 14 days on four different dose groups of experimental animals. The subchronic toxicity&#xD;
test was carried out for 28 days using three other dose groups of experimental animals. Results: The administration&#xD;
of a single dose of IHDM allergenic extract at various doses did not cause mice behaviour changes, and no death&#xD;
was shown in each group. Likewise, there was no change in the principal organs by macroscopic observations.&#xD;
Meanwhile, administering IHDM allergenic extract at repeated doses for 28 days could show signs of toxicity. The&#xD;
symptoms were shown in the histopathological structure of the liver, kidney, and heart organs. Conclusion: It can&#xD;
be concluded that the IHDM allergenic extract is safe for single-dose administration but shows toxic signs when&#xD;
given in repeated doses. Further tests are needed for 90 days of subchronic toxicity and satellite testing.&#xD;
Keywords: acute toxicity, subchronic toxicity, IHDM safety, asthma allergy, neglected disease</summary>
    <dc:date>2022-08-31T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Analysis of Antibiotic Use in COVID-19 Patients at a Hospital in Sidoarjo</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/7483" />
    <author>
      <name>Kristanti, Weni</name>
    </author>
    <author>
      <name>Yulia, Rika</name>
    </author>
    <author>
      <name>Herawati, Fauna</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/7483</id>
    <updated>2024-11-07T04:36:45Z</updated>
    <published>2022-08-31T00:00:00Z</published>
    <summary type="text">Title: Analysis of Antibiotic Use in COVID-19 Patients at a Hospital in Sidoarjo
Authors: Kristanti, Weni; Yulia, Rika; Herawati, Fauna
Abstract: Abstract&#xD;
Background: Antibiotics are given to COVID-19 patients to treat bacterial co-infections, but excessive and&#xD;
inappropriate antibiotic use can increase antibiotic resistance. Objective: The study aims to analyze the&#xD;
antibiotic use and bacterial susceptibility in COVID-19 patients at a hospital in Sidoarjo - East Java. Method:&#xD;
The research design used was a prospective cross-sectional study using data collection of sputum culture,&#xD;
bacterial susceptibility, medical records, and Pharmacy antibiotics usage from August to October 2021. The&#xD;
Research sample is moderate-to-severe COVID-19 patients. Result: The results showed that in August-October&#xD;
2021, 32 patients met the study sample category, where the most were men (56.25%), age range 46-55 years&#xD;
(31.25%), and outcome recovered as much as 81.25%. The culture results showed that only 1 (one) person out of&#xD;
32 samples had bacterial growth. The only bacteria that grew in the sputum culture was Enterobacter aerogenes,&#xD;
susceptible to meropenem but resistant to levofloxacin. The highest quantity of antibiotics in this study was&#xD;
levofloxacin 71,16; meropenem 32.25; moxifloxacin 21.84 DDD/ 100 bed days. Conclusions: Most of the cases&#xD;
of COVID-19 occurred in men; the age range was 46-55 years, and the outcome recovered was more than those&#xD;
who died. Bacterial co-infection occurred in 3.12% of patients who received meropenem and levofloxacin during&#xD;
their hospitalization. The largest quantity of antibiotics used was levofloxacin, meropenem, and moxifloxacin.&#xD;
The combination of meropenem and levofloxacin should be re-evaluated because levofloxacin is resistant but&#xD;
still susceptible to meropenem.&#xD;
Keywords: COVID-19, antibiotics resistant, sputum culture, ATC/DDD methodology</summary>
    <dc:date>2022-08-31T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>The ABC Analysis of Drug Use and Cost in Cardiology Outpatients - National Health Insurance</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/7480" />
    <author>
      <name>Suprapti1, Budi</name>
    </author>
    <author>
      <name>Yusuf, M.</name>
    </author>
    <author>
      <name>Debby Saraswati, Marcha</name>
    </author>
    <author>
      <name>Febriana Astuti, Selvia</name>
    </author>
    <author>
      <name>Damayanti, Dewi</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/7480</id>
    <updated>2024-11-07T04:32:13Z</updated>
    <published>2022-08-31T00:00:00Z</published>
    <summary type="text">Title: The ABC Analysis of Drug Use and Cost in Cardiology Outpatients - National Health Insurance
Authors: Suprapti1, Budi; Yusuf, M.; Debby Saraswati, Marcha; Febriana Astuti, Selvia; Damayanti, Dewi
Abstract: Abstract&#xD;
Background: Cardiovascular disease is one of the chronic diseases with an increasing prevalence from year to&#xD;
year. The results of Indonesia's basic health research (RISKESDAS 2018) showed that it was experienced by 2.9%&#xD;
of the population. Ensuring the continuity of drug availability is very important in pharmacy services for this&#xD;
patient group. The history of drug use is considered in the planning dan procurement of drug products. Objective:&#xD;
This study aims to analyze the drug use pattern and cost of drugs for cardiology outpatients in the National Health&#xD;
Insurance scheme (JKN). Methods: A retrospective observational study was conducted using the prescription of&#xD;
cardiology outpatients JKN for March-May 2021. The ABC method carried out the analysis of drug use patterns&#xD;
and cost. Results: From 2,986 prescriptions for cardiovascular disease, there were 94 types of drugs from 37&#xD;
therapeutic classes. In the ABC analysis of drug use for class A, 68.82% contained seven types of drugs, class B,&#xD;
20.55% contained nine types of drugs, and class C, 10.63% with 78 types of drugs. The results of ABC analysis&#xD;
for investment value (cost) of drugs class A 66.96% contained two types of drugs, class B 19.81% with four types&#xD;
of drugs, and class C 14.23% with 88 types of drugs. Conclusion: ABC analysis of the drug use pattern and&#xD;
cost/investment showed different patterns which had value to consider in procurement planning to maintain service&#xD;
continuity.&#xD;
Keywords: drug usage, cost, abc analysis, cardiovascular disease, JKN</summary>
    <dc:date>2022-08-31T00:00:00Z</dc:date>
  </entry>
</feed>

